Skip to main content
Skip to footer


2bPrecise helps clinicians leverage the power of genetics and genomics within their clinical workflow for better disease risk identification, improved medication safety and efficacy, earlier diagnosis and faster treatment.

In-workflow availability of patients’ genomic profile – within the context of phenotypical information and with one-click access to critical precision medicine knowledgebases – vastly improves clinical decision making. The 2bPrecise™ platform consumes data directly from virtually any testing lab and integrates it within the provider’s native EHR. It consolidates discrete results into an invaluable data set that can be leveraged in myriad ways – driving efficient workflows for patient-specific genomic interventions, extracting population analytics, building cohorts for trial recruitment, enabling participation in research studies and more.

  • Optimizes a manual, document-driven process and delivers a consolidated view of patient results
  • Simplifies workflows and connects care teams across the enterprise – providers, genetic counselors, pathologists, pharmacists, etc.
  • Delivers a consistent clinical experience across the organization when providers access genomics, no matter what EHR they use
  • Enables leadership to govern clinical practice around genetic/genomic testing for greater efficiency and value
  • Use Cases

    • 2bPrecise Pedigree tool helps clinicians at the point of care capture and visualize critical family history details. This enables them to identify individuals at greatest risk for heritable conditions across a wide range of clinical areas – oncology (e.g., Lynch syndrome), cardiovascular (cardiomyopathies), neurology (Alzheimer’s), maternal-fetal, etc. With these insights, clinicians can determine which patients might benefit from germline testing which, in turn, enables them to instigate more aggressive preventive, screening and early diagnostic activities.
    • 2bPrecise pharmacogenomic (PGx) decision support allows physicians to determine which medications (current and future) will be most effective and safest for individual patients. Delivered within the EHR workflow, 2bPrecise PGx equips clinicians with insights to end “trial-and-error” prescribing so they arrive at the best choice as the first or second line of therapy.
    • 2bPrecise precision oncology functionality brings results from tumor testing (somatic) – often repeated throughout the patient’s treatment – into the oncology workflow to speed and improve outcomes. Clinicians can also view a comprehensive patient-centric diagnostic and treatment timeline to guide clinical decisions, as well as identify genetic factors present within the somatic result that indicate patient risk for secondary cancers and elevated risks for patients’ family members.
    • 2bPrecise germline decision support capabilities reveal patients’ risk for heritable conditions to drive preventive care and early intervention, and highly accurate diagnoses. This helps reduce overall disease burden to improve outcomes, reduce costs and enhance patient quality of life.

    Supported Devices

    • Desktop
    • Tablet
    • Smartphone

    Version Details

    Compatible with Cerner Powerchart

    Key Features

    Patient Summary

    With a single-click, providers can access a Patient Summary with a roll-up view of all genomic results available for the individual, minimizing clinical workflow disruption and averting alert fatigue.


    2bPrecise Pedigree helps providers identify candidates for genetic/genomic testing. It facilitates referrals for genetic counseling and – incorporated as discrete data within a larger precision medicine solution – can be used with genotype/phenotype information to power underlying analytics.


    Access to information about drug-gene interactions while the provider makes prescribing decisions lessens the burden on pharmacists and helps patients get the safest, most effective therapy sooner. Because 2bPrecise incorporates a curated PGx knowledge source, results can be re-interrogated to inform future prescribing decisions based on the latest actionable guidelines.

    Precision Oncology Somatic View

    Molecular profiles of tumor tissue, delivered directly into the oncology workflow, empower providers to determine the treatment most likely to produce the best results. The information likewise helps match patients with clinical trials by interrogating molecular inclusion and exclusion criteria ingested from a Clinical Trials Management System or other clinical trial databases.